These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 5594286)
21. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases]. Vittori C; Taborelli G; Taborelli R Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172 [No Abstract] [Full Text] [Related]
22. [31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy]. Sinitsyn VE; Veselova TN; Bakharev AO; Karpov IuA Ter Arkh; 1996; 68(12):69-72. PubMed ID: 9054047 [No Abstract] [Full Text] [Related]
23. [Intra-arterial histamine therapy]. Laroche GP Union Med Can; 1971 Dec; 100(12):2402-3. PubMed ID: 5163037 [No Abstract] [Full Text] [Related]
24. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans]. Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736 [TBL] [Abstract][Full Text] [Related]
25. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature]. Gemma GB; Ghezzi P; Cavaliere P Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730 [No Abstract] [Full Text] [Related]
27. [Erosion of the femoral artery after intra-arterial infusions of drugs in arteriosclerosis obliterans]. Ivanenko AA; Rodin IuV; Belinskiĭ VE Vestn Khir Im I I Grek; 1984 Mar; 132(3):133-4. PubMed ID: 6719755 [No Abstract] [Full Text] [Related]
28. [Ways to enhance the efficacy of treating patients with the terminal stage of arterial ischemia of the lower extremities]. Lebedev LV; Afonin DN Vestn Khir Im I I Grek; 1995; 154(1):54-7. PubMed ID: 7792994 [TBL] [Abstract][Full Text] [Related]
29. The significance of vasodilator therapy in obliterative arterial disease. Thulesius O Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925 [No Abstract] [Full Text] [Related]
30. Long-term results of omental transplantation for chronic occlusive arterial diseases. Hoshino S; Nakayama K; Igari T; Honda K Int Surg; 1983; 68(1):47-50. PubMed ID: 6853083 [TBL] [Abstract][Full Text] [Related]
31. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature]. Ghezzi P; Cavaliere P; Berti Riboli E Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731 [No Abstract] [Full Text] [Related]
32. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations]. Bonessa C; Cremonini L Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708 [No Abstract] [Full Text] [Related]
33. [Contribution to the therapy of juvenile and arteriosclerotic chronic peripheral obliterating artery diseases with a new sympatholytic drug]. Stoppani L; Lo Cuoco A Minerva Cardioangiol; 1966 Mar; 14(3):163-5. PubMed ID: 5937431 [No Abstract] [Full Text] [Related]
34. [Results of Halidor therapy of arterial stenosis]. Lengyel J; Szabó I; László L Orv Hetil; 1968 May; 109(21):Suppl:31-2. PubMed ID: 5713398 [No Abstract] [Full Text] [Related]
35. [Treatment of chronic arterial insufficiency of legs with midocalm in elderly]. Briskin BS; Dibirov MD; Evseev IuN; Novosel'tsev OS Khirurgiia (Mosk); 2000; (4):52-4. PubMed ID: 10800314 [No Abstract] [Full Text] [Related]
36. [Extraperitoneal approach in treatment of chronic obliteration of the aorta and iliac arteries. 6 personal cases]. Descotes J; Vieville C; Vuillard P; Marques A; Van Gestel R Lyon Chir; 1968; 64(3):352-60. PubMed ID: 5738673 [No Abstract] [Full Text] [Related]